IDH1 and neoplasm: In both groups, high CD45, high CD4 count, high CD8 count, gender, receiving radiotherapy alone, TMZ therapy alone, salvage gamma knife (GKS) treatment, or tumor cells expressing IDH1 mutation, and MGMT methylation were all not significant prognostic factors under HR evaluation.